Clinical trial NCT02141555 - References

Spontaneous Abortion in First Trimester — Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss

Citation(s)

•   Aronsson A, Fiala C, Stephansson O, Granath F, Watzer B, Schweer H, Gemzell-Danielsson K
  Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol. Hum Reprod. 2007 Jul;22(7):1912-8. Epub 2007 May 8.
•   Danielsson KG, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M
  Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 1999 Feb;93(2):275-80.
•   Doubilet PM, Benson CB, Bourne T, Blaivas M; Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy, Barnhart KT, Benacerraf BR, Brown DL, Filly RA, Fox JC, Goldstein SR, Kendall JL, Lyons EA, Porter MB, Pretorius DH, Timor-Tritsch IE
  Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med. 2013 Oct 10;369(15):1443-51. doi: 10.1056/NEJMra1302417. Review.
•   Fjerstad M, Trussell J, Sivin I, Lichtenberg ES, Cullins V
  Rates of serious infection after changes in regimens for medical abortion. N Engl J Med. 2009 Jul 9;361(2):145-51. doi: 10.1056/NEJMoa0809146.
•   Herting RL, Clay GA
  Overview of clinical safety with misoprostol. Dig Dis Sci. 1985 Nov;30(11 Suppl):185S-193S.
•   Jones RK, Kost K
  Underreporting of induced and spontaneous abortion in the United States: an analysis of the 2002 National Survey of Family Growth. Stud Fam Plann. 2007 Sep;38(3):187-97.
•   Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD
  Misoprostol administered by epithelial routes: Drug absorption and uterine response. Obstet Gynecol. 2006 Sep;108(3 Pt 1):582-90.
•   Middleton T, Schaff E, Fielding SL, Scahill M, Shannon C, Westheimer E, Wilkinson T, Winikoff B
  Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception. 2005 Nov;72(5):328-32. Epub 2005 Aug 9.
•   Saraiya M, Berg CJ, Shulman H, Green CA, Atrash HK
  Estimates of the annual number of clinically recognized pregnancies in the United States, 1981-1991. Am J Epidemiol. 1999 Jun 1;149(11):1025-9.
•   Schaff EA, DiCenzo R, Fielding SL
  Comparison of misoprostol plasma concentrations following buccal and sublingual administration. Contraception. 2005 Jan;71(1):22-5.
•   Schaff EA, Fielding SL, Westhoff C
  Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception. 2001 Aug;64(2):81-5.
•   Sedgh G, Henshaw S, Singh S, Ahman E, Shah IH
  Induced abortion: estimated rates and trends worldwide. Lancet. 2007 Oct 13;370(9595):1338-45.
•   Tang OS, Gemzell-Danielsson K, Ho PC
  Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2:S160-7. Epub 2007 Oct 26. Review.
•   Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC
  Incidence of early loss of pregnancy. N Engl J Med. 1988 Jul 28;319(4):189-94.
•   Winikoff B, Dzuba IG, Creinin MD, Crowden WA, Goldberg AB, Gonzales J, Howe M, Moskowitz J, Prine L, Shannon CS
  Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial. Obstet Gynecol. 2008 Dec;112(6):1303-10. doi: 10.1097/AOG.0b013e31818d8eb4.

Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss: a Pilot Randomized Controlled Trial

Details for clinical trial NCT02141555